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Background & objectives: The occupational and non-occupational exposure to hexavalent
chromium Cr (VI) is common. The effect of chromium compromises the immune response of the
host. Dengue virus (DV) infection causes various changes in the peripheral blood cells. It is,
therefore, possible that the chromium toxicity may affect the disease process during DV infection.
The present study aims to  study the effects of dengue virus infection on peripheral blood cells of
mice fed Cr (VI) with drinking water.
Methods: One group of mice was given ad libitum drinking water containing Cr (VI) and the
other group used as  the normal control mice was given plain water to drink. At the 3, 6 and 9 wk
of Cr (VI) drinking, a set of mice from each group was inoculated intracerebrally (ic) with DV
and studied at the 4th and 8th day post inoculation.
Results: It was observed that Cr (VI) drinking led to reduction in lymphocytes, haemoglobin
and the haematocrit values while the granulocyte, monocyte and platelet counts were increased.
On the other hand, most of the parameters were decreased following inoculation of normal mice
with DV. In Cr (VI)-fed mice the effects of DV infection were minimal.  The most significant
finding of these experiments was that the reduction in platelet counts following inoculation with
DV was markedly less in Cr (VI)-fed mice than that in DV-inoculated normal control mice.
Interpretation & conclusion: Cr(VI) compounds have been declared as a potent occupational
carcinogen. On the contrary, Cr(III) salts such as chromium polynicotinate, chromium chloride
and chromium picolinate, are used as micronutrients and nutritional supplements, and have
been shown to exhibit health benefits in animals and humans. Whether therapeutic doses of
chromium (III) compounds may be able to prevent the DV-induced fall in platelet counts, needs
to be investigated.
Hexavalent chromium [Cr (VI)] occurs naturally
in the environment and is widely used in paints, metal
finishes, steel including stainless steel manufacturing,
alloy cast irons, chrome and wood treatment and
leather tanning. Cr (VI) ingested with food such as
vegetables, meat, etc., is reduced to Cr (III) before
entering the blood stream. Cr (VI) is highly toxic to
all forms of living organisms1-3. Chromium enters the
body through the lungs, gastrointestinal tract, and to
a lower extent through skin4. Non-occupational
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exposure occurs via ingestion of chromium containing
food and water5. Regardless of route of exposure,
Cr(III) is poorly absorbed whereas Cr(VI) is more
readily absorbed4. Cr (VI) compounds that enter the
bloodstream are transported into red blood cells
(RBCs) via sulphate anion channels6. Cr(VI) is rapidly
reduced to Cr(III) via unstable intermediates [Cr(V)
and Cr(IV)] inside the RBC. The reduced product
binds to haemoglobin and other intracellular proteins,
resulting in elevation of total chromium levels in the
RBC fraction of blood for several weeks6-8. The main
routes for the excretion of chromium are via kidney/
urine and the bile/feces5,9.
During dengue virus (DV) infection various
changes occur in the peripheral blood cells. The total
leucocyte count in patients with dengue infection
varies from mild leucopaenia to moderate leucocytosis
with predominance of lymphocytes. The haematocrit
value increases during the first three days but
gradually decreases from day four to nine. The platelet
count is usually normal during the first three days.
Thrombocytopaenia in more than 80 per cent cases
begins during febrile stage and reaches its lowest value
during the haemorrhagic phase (dengue haemorrhagic
fever, DHF) of illness10. Thrombocytopaenia is one
of the simple diagnostic criteria proposed by World
Health Organization (WHO) for diagnosis of DHF11.
Constant haematological abnormalities occurring in
DHF include bone marrow suppression, leucopaenia
and thrombocytopaenia12. DV does not produce any
clinical illness in any animal species and there is no
animal model similar to human DHF. In absence of
such a model, inoculated mice have been used
extensively to answer several questions related to
dengue infection13-18.
DV infection is endemic all over India so is the
occupational and non-occupational exposure to Cr
(VI). The effect of chromium compromises the immune
response of the host20. It is, therefore, possible that
the chromium toxicity may affect the disease process
during DV infection. The present experiments were,
therefore, conducted to study the effects of dengue
virus infection on peripheral blood cells of mice fed
Cr (VI) with drinking water.
Material & Methods
Animals: The study was carried out on Swiss mice
weighing 25-30 g, aged 6-8 wk obtained from the
animal breeding facility of the Industrial Toxicology
Research Centre, Lucknow. Clearance from the
Animal Ethical Commettee of the Institute was
obtained for the use of animals. Mice were maintained
on pellet diet.
Plan of study: One group of mice (n=72) were given
ad libitum drinking water containing Cr (VI) and the
second group (n=24) was given plain water to drink
(Fig.1). At the 3, 6 and 9 wk of Cr (VI) drinking,
a group of mice (12 animals in each group) were
inoculated ic with dengue virus in doses of 1000
LD50
13
. The mice were killed in groups at days
4 (6 animals) and 8 (6 animals) post virus inoculation
(pi) and various investigations were done.
Chromium treatment of mice: Each group with 6 mice
was given ad libitum drinking water containing 250
ppm chromium (VI) in form of potassium dichromate
for 3, 6 and 9 wk. Oral LD50 values for Cr(VI)
compounds was 300 mg/kg for potassium chromate
in the mouse19. From the daily consumption of water
it was found that the average daily intake of Cr (VI)
per mouse was 14.8 mg/kg.
Dengue virus: Dengue type 2 virus (DV), strain
P23085 (kindly supplied by the Director, National
Institute of Virology, Pune) and was used in the form
of infected infant mouse brain suspension13. Mice were
inoculated with 1000 LD50 of DV intracerebrally (ic)
in doses of 0.03 ml.
Collection of blood sample:  Animals were sacrificed
and blood samples were collected from the jugular
vein in tubes containing 0.5 ml freshly prepared 10
per cent K3 EDTA solution as anticoagulant. The
samples were shaken gently.
Haematological study: The following estimations were
performed immediately with the help of a fully
automatic haematology analyzer (Bayer; Technicon
H1*E, USA):  total leucocyte count (TLC), differential
leucocyte count (DLC), total RBC count, haematocrit
(Hct), haemoglobin (Hb), mean corpuscular volume
(MCV), mean corpuscular haemoglobin concentration
(MCHC) and platelet counts.
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Table I. Leucocytes count in Cr (VI) fed mice after dengue virus (DV) infection
Cr TLC (103/µl) Lymphocytes (%) Granulocytes (%) Monocytes (%)
treated Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d
group
0 wk 7.0±0.9 3.1±0.5+ 5.1±0.9** 83±1.0 87±5.0 80±3.0 11±0.9 11±5.0 18±2.0 3±0.1 2±0.5 3±1.0
3 wk 5.2±1.0** 4.2±1.2+ 4.6±0.9+ 70±8.0+ 45±3.0+ 42±5.0+ 21±8.0** 48±3.0+ 50±5.0+ 9±1.0+ 7±1.0+ 8±2.0+
6 wk 6.8±0.9 5.7±1.2* 5.9±1.4 66±6.0+ 50±3.0+ 47±5.0+ 23±5.0** 42±3.0+ 45±5.0+ 11±2.0+ 8±3.0+ 8±3.0+
9 wk 5.8±1.0 3.4±0.7+ 4.3±1.3+ 50±60+ 40±12+ 30±6.0+ 35±7.0+ 50±15+ 62±6.0+ 15±3.0+ 10±1.0+ 8±2.0+
Control, normal mice; DV4d, 4th day after infection DV; DV8d, 8th day after infection with DV
P*<0.05, **<0.01, +<0.001 compared to controls
Table II. Red blood cell indices of Cr (VI) fed mice after dengue virus (DV) infection
Chronium DV infected group
treated RBC (106 µl) MCV (fl) Hct (%) MCHC (g/dl) Hb (g/l)
group Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d
0 wk 8.3±0.3 5.2±0.5+ 5.9±0.3** 46±0.3 44±0.8 44±0.5 38±0.1 22.3±2.0+ 24.2±0.2+ 30.2±0.4 30.9±1.4 30.8±0.6 12.8±0.1 6.9±0.6** 7.4±0.0*
3 wk 11±1.0** 9.1±1.0 11±1.4** 39±2.0 40±0.7 41±4.2 40±3.6 35.3±4.5 45.0±9.0 29.9±1.4 32.2±0.5 29.1±5.4 12.0±0.7 11±1.3 12.7±3
6 wk 8.2±0.2 8.2±1.0 7.4±0.5 50±2.3 50±3.0 53±3.0 39±3.0 40.0±1.0 39.3±1.4 29.0±2.0 29.0±2.0 28.1±1.0 11.3±0.2 11.0±0.5 11±0.7
9 wk 7.0±0.5 8.0±0.8 6.2±0.6** 37±1.0 36±0.9* 35±1.0* 25.9±2+ 28.0±3.0** 22.0±2.0+ 35.0±1.0 33.6±0.5 37.2±4.0 9.02±0.7* 8.94±0.9* 7.6±0.2*
Control, normal mice; DV4d, 4th day after infection with DV; DV8d, 8th day after infection with DV; RBC, red blood cell; MCV, mean corpuscular volume; HCt, haematocrit;
MCH, mean corpuscular haemoglobin;  MCHC, mean corpuscular haemoglobin concentration; RDW, red blood cell distribution width; Hb, haemoglobin
P *<0.05, **<0.01, +<0.001 compared to controls
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Statistical analysis: Two-way analysis of variance
(Two-way ANOVA) was done to compare the mean
values of the outcome variables (TLC, DLC, RBC
count, Hb, Hct, MCV, MCHC, and platelet count)
considering chromium exposure and dengue virus
infection to animals as independent variables. Prior
to this homogeneity of variance between the treated
groups were ascertained. The two-group comparison
was done by calculating least significant difference
at 5 per cent level of significance.
Results
Effects of dengue virus inoculation on mice: The mice
remained apparently healthy up to the day 4 of DV
inoculation. The back was arched and the fur was
ruffled from day 5 pi. By the 8th day the mice became
seriously ill with the development of hind limb
paralysis and all of them died by the day 10 pi.
Therefore, the experiments were conducted on days
4 and 8 post inoculation of the dengue virus. The
clinical dengue illness in Cr (VI)-fed mice was similar
to that in normal mice.
Effects on leucocytes: In normal control mice the total
leucocyte count was 7±0.9x103/µl with 83 per cent
lymphocytes and 11 per cent granulocytes. By giving
Cr(VI) in drinking water for 3 wk the total count was
reduced  significantly (P<0 .01) to 5.2±1x103/µl, with
21 per cent granulocytes. At the 6th and 9th wk the
total leucocyte counts recovered slightly but the
percentage of granulocytes and monocytes was
increased significantly (P<0.01, P<0.001) with
consequent reduction in lymphocytes (Table I). When
the normal mice were inoculated ic with DV, a
reduction in the total leucocyte count was seen at the
day 4. On day 8 there was little improvement in the
counts. The predominant cells in the blood remained
lymphocytes in all the groups (Table I). Total leucocyte
counts were reduced at 3 and 9 wk in Cr(VI)-fed mice
given DV as compared to normal controls. A marked
increase in the percentage of granulocytes was seen
at all the periods of Cr(VI) drinking with the
consequent decrease in the lymphocytes  (Table I).
Effects on red blood cells: The total red blood cell
(RBC) count in normal mice was 8.3 ± 0.3 µl. By
feeding Cr(VI) the red blood cell count increased
significantly (P<0.001) to 11.6 ± 1.7x106 µl. This was
associated with a slight reduction in the mean
corpuscular volume and mean corpuscular
haemoglobin. At the 6th and 9th wk there was not
much change in total RBC count but the haematocrit
(P<0.001) and the haemoglobin (P<0.01)
concentration was reduced especially at the 9th wk
(Table II). Normal mice inoculated with DV showed
reduced total RBC counts (P<0.001), haematocrit
value (P <0.001) and haemoglobin  (P <0.01)
concentration at day 4 of DV inoculation (Table II).
These values remained low at day 8 pi also. When
Cr(VI) fed mice were inoculated with DV the total
RBC count remained more or less similar in the 3rd
and the 6th wk to that in controls while at day 8 after
DV of the 9th wk Cr exposure the reduction was
significant (P <0.01) (Table II).
Effects on platelets: The platelet count in the blood
of normal control mice was 370 ± 15x106/µl with
Cr(VI) drinking the total platelet count was
significantly increased to 622 ±128 x106/µl (P<0.001)
Table III. Platelet counts during dengue virus (DV) infection in Cr (VI) fed mice
Cr DV infected group
treated MPV PDW
group Control DV4d DV8d Control DV4d DV8d
0 wk 7.0±0.2 6.8±0.1 5.9±0.2* 9.0±0.5 8.3±0.3 8.8±0.1
3 wk 5.2±0.3* 5.3±0.2* 5.9±0.5* 5.9±0.6** 6.2±0.4* 6.9±1.7*
6 wk 6.0±0.5 5.9±1.0* 6.9±0.5 7.1±0.7* 6.8±0.8* 7.0±2.0*
9 wk 6.3±0.2 6.4±0.3 6.5±0.5 8.0±0.7 8.1±1.7 7.0±1.0*
Control, normal mice; DV4d, 4th day after infection with DV; DV8d, 8th day after infection with DV; MPV, mean platelet volume;
PDW, platelet distribution width
P *<0.05, **<0.01 compared to normal controls
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Fig. 1. Schematic presentation of the plan of study. DVic, mice inoculated with dengue virus intracerebrally; Nil, mice not given dengue virus; 4d, mice killed on the
4th day of the virus inoculation; 8d, mice killed on the 8th day of the virus inoculation; mice not given virus were also killed on the similar days. The number of mice
in each group has been presented in parenthesis.
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at the 3 wk to 736 ± 185 x106/µl (P<0.001) at the 9th
wk compared to normal controls. When normal control
mice were inoculated with the dengue virus, a
significant reduction in the platelet count was seen
both at days 4 and 8 being 185 ± 67 (P<0.01) and
254 ± 71x106 (P<0.05) respectively (Fig.2). When
Cr(VI) treated mice were inoculated with dengue virus,
the virus-induced reduction in platelet count was not
observed at all the periods as the counts remained
401±120 to 628 ±70x106/µl. It was observed that by
drinking Cr(VI)  the mean platelet volume was slightly
reduced. A greater change was observed in platelet
distribution width by drinking Cr(VI) (Table III).
When normal mice were inoculated with DV slight
change was observed in platelet distribution width and
the mean platelet volume (Table III). Inoculation of
dengue virus in Cr(VI) treated mice resulted in the
decrease of mean platelet volume (P<0.01) especially
at 3 wk (Table III).
Discussion
The findings of the present study showed a marked
reduction in lymphocyte percentage and increase in
the granulocyte, monocyte and platelet counts in mice
fed Cr(VI) with  drinking water. Differential leucocyte
counts revealed that percentage of lymphocytes
decreased by 50 per cent while the percentage of
polymorphonuclears and monocytes was increased
gradually. Similar findings have been reported in fish
exposed to chromium21. Rats exposed to atmosphere
containing soluble potassium chromate have
significantly increased levels of polymorphonuclear
cells and monocytes22. A significant increase in
polymorphonuclear cells has been reported in a 25 yr
old women who drank a solution containing potassium
dichromate23. The normal mice inoculated with DV
showed a 48 per cent decrease in total leucocyte count.
The number of polymorphonuclears was also reduced
in the present study. Patients with dengue fever have
mild leucopaenia to mild leucocytosis associated with
lymphocytosis11,24. The  interesting finding in the
present study was that Cr(VI)-fed mice inoculated
with DV showed marked reduction in number of
lymphocytes, while the number of polymorphonuclears
was not affected significantly.
At three week of Cr(VI) drinking the red blood cell
count was increased by 29 per cent while at 6th and
9th wk it remained the same in our study. Glaser et
al25,26 reported that rats exposed to Cr(VI) for
18 months had increased red blood cell counts.
A reduction in MCV and MCHC was observed at the
end of 3rd wk of Cr(VI) drinking. Rats and mice fed
with potassium dichromate showed slightly reduced
MCV and MCH values at earlier periods and low doses
of Cr (VI) but the decrease was marked with the higher
doses given for longer periods27-29. In the present study,
it was observed that after 9 wk of Cr(VI) drinking
Fig. 2. Effects of subtoxic dose of Cr (VI) on platelets
during dengue virus infection. Cr, chromium; DV, dengue virus;
4, 8 days after the virus infection. P *<0.05, ** <0.01,
***<0.001 compared to normal controls.
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haematocrit and haemoglobin contents were decreased.
The decrease in haemoglobin appears to be due to
inhibition of its biosynthesis. In the initial stage of
pathway, succinyl Co-A combines with glycine to form
the first of the intermediates, δ-amino levulinic acid.
Chromium may cause an increase in SDH synthesis
and therefore decrease the succinyl Co-A pool. It may
also interact with serine, which is the precursor of
glycine and may thus decrease the serine pool.
Chromium causes the DNA damage, producing
inhibition of the activities of one or more enzymes
involved in heme synthesis30,31. Sharma et al32 have
reported that in an 18 yr old women who ingested few
grams of potassium dichromate showed decreased
haemoglobin and haematocrit on day 4 after ingestion.
In another study, a 44 yr old man had decreased
haemoglobin levels 9 days after ingestion of
chromium33 .
Haemoglobin concentration was decreased by 42
per cent on day 8 in normal mice inoculated with DV.
The haematocrit value was also decreased by 40 per
cent. Pimpan and Prasert11 reported that in patients
with DHF haematocrit value increased initially but
later on it  decreased. Gastrointestinal bleeding might
initially be occult and usually manifested as a drop in
haematocrit without clinical improvement34,35. Cr(VI)
feeding led to an increase in platelet counts in the
present study, while in normal mice inoculated with
DV, platelet count was decreased significantly at days
4 and 8 post inoculation. Thrombocytopenia is one of
the simple diagnostic criteria proposed by the WHO
for clinical diagnosis of DHF11. The cause of
thrombocytopenia is either impaired megakaryocytes
production or increased platelet distruction10.
Cr(VI) compounds have been declared as a potent
occupational carcinogen among workers in chrome
plating, stainless steel, and pigment industries3. The
cells of immune system have capacity to reduce toxic
Cr (VI) to non-toxic Cr (III) and in the process some
immune functions are disturbed20,36. On the contrary,
Cr (III) salts such as chromium polynicotinate,
chromium chloride and chromium picolinate, are used
as micronutrients and nutritional supplements, and
have been demonstrated to exhibit  significant health
benefits in animals and humans9,37,38.
In conclusion, the reduction in platelet counts
following inoculation with DV was markedly less in
Cr (VI)-fed mice than that seen in DV-inoculated
normal control mice. Further studies need to be done
to see whether Cr (III) therapy with chromium
polynicotinate, chromium chloride or chromium
picolinate will be able to prevent the pathognomonic
fall in platelet count in patients with dengue virus
infection.
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